88 related articles for article (PubMed ID: 23388503)
1. Chemosensitizing acridones: in vitro calmodulin dependent cAMP phosphodiesterase inhibition, docking, pharmacophore modeling and 3D QSAR studies.
Rajendra Prasad VV; Deepak Reddy G; Appaji D; Peters GJ; Mayur YC
J Mol Graph Model; 2013 Mar; 40():116-24. PubMed ID: 23388503
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies.
Rajendra Prasad VV; Peters GJ; Lemos C; Kathmann I; Mayur YC
Eur J Pharm Sci; 2011 Jul; 43(4):217-24. PubMed ID: 21565270
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of chemosensitization effect of acridones in cancer cell lines: Combined pharmacophore modeling, 3D QSAR, and molecular dynamics studies.
Gade DR; Makkapati A; Yarlagadda RB; Peters GJ; Sastry BS; Rajendra Prasad VVS
Comput Biol Chem; 2018 Jun; 74():63-75. PubMed ID: 29547875
[TBL] [Abstract][Full Text] [Related]
4. Structural insights of JAK2 inhibitors: pharmacophore modeling and ligand-based 3D-QSAR studies of pyrido-indole derivatives.
Gade DR; Kunala P; Raavi D; Reddy PK; Prasad RV
J Recept Signal Transduct Res; 2015 Apr; 35(2):189-201. PubMed ID: 25140764
[TBL] [Abstract][Full Text] [Related]
5. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
Halder AK; Saha A; Saha KD; Jha T
J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
[TBL] [Abstract][Full Text] [Related]
6. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
Tripuraneni NS; Azam MA
J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR studies of some tetrasubstituted pyrazoles as COX-II inhibitors.
Gupta GK; Kumar A
Acta Pol Pharm; 2012; 69(4):763-72. PubMed ID: 22876620
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists.
Mustyala KK; Chitturi AR; Naikal James PS; Vuruputuri U
J Recept Signal Transduct Res; 2012 Apr; 32(2):102-13. PubMed ID: 22384789
[TBL] [Abstract][Full Text] [Related]
9. Pharmacophore modeling, virtual screening and 3D-QSAR studies of 5-tetrahydroquinolinylidine aminoguanidine derivatives as sodium hydrogen exchanger inhibitors.
Bhatt HG; Patel PK
Bioorg Med Chem Lett; 2012 Jun; 22(11):3758-65. PubMed ID: 22546667
[TBL] [Abstract][Full Text] [Related]
10. Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors.
Dhanachandra Singh Kh; Karthikeyan M; Kirubakaran P; Nagamani S
J Mol Graph Model; 2011 Sep; 30():186-97. PubMed ID: 21831680
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2,4-dimethylacridones as anticancer agents.
Murahari M; Kharkar PS; Lonikar N; Mayur YC
Eur J Med Chem; 2017 Apr; 130():154-170. PubMed ID: 28246041
[TBL] [Abstract][Full Text] [Related]
12. Chloro acridone derivatives as cytotoxic agents active on multidrug-resistant cell lines and their duplex DNA complex studies by electrospray ionization mass spectrometry.
Rajendra Prasad VV; Venkat Rao J; Giri RS; Sathish NK; Shanta Kumar SM; Mayur YC
Chem Biol Interact; 2008 Nov; 176(2-3):212-9. PubMed ID: 18638463
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR pharmacophore modeling and in silico screening of new Bcl-xl inhibitors.
Almerico AM; Tutone M; Lauria A
Eur J Med Chem; 2010 Nov; 45(11):4774-82. PubMed ID: 20728251
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore modeling, 3D-QSAR, and docking study of pyrozolo[1,5-a]pyridine/4,4-dimethylpyrazolone analogues as PDE4 selective inhibitors.
Tripuraneni NS; Azam MA
J Mol Model; 2015 Nov; 21(11):289. PubMed ID: 26499496
[TBL] [Abstract][Full Text] [Related]
15. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
Wei HY; Lu CS; Lin TH
J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore, 3D-QSAR, and Bayesian model analysis for ligands binding at the benzodiazepine site of GABAA receptors: the key roles of amino group and hydrophobic sites.
Yang Y; Zhang W; Cheng J; Tang Y; Peng Y; Li Z
Chem Biol Drug Des; 2013 May; 81(5):583-90. PubMed ID: 23279907
[TBL] [Abstract][Full Text] [Related]
17. Virtual screening studies on HIV-1 reverse transcriptase inhibitors to design potent leads.
Vadivelan S; Deeksha TN; Arun S; Machiraju PK; Gundla R; Sinha BN; Jagarlapudi SA
Eur J Med Chem; 2011 Mar; 46(3):851-9. PubMed ID: 21272964
[TBL] [Abstract][Full Text] [Related]
18. Design of novel quinazolinone derivatives as inhibitors for 5HT7 receptor.
Chitta A; Jatavath MB; Fatima S; Manga V
J Recept Signal Transduct Res; 2012 Feb; 32(1):3-16. PubMed ID: 22171569
[TBL] [Abstract][Full Text] [Related]
19. Key features for designing phosphodiesterase-5 inhibitors.
Chang TT; Huang HJ; Lee KJ; Yu HW; Chen HY; Tsai FJ; Sun MF; Chen CY
J Biomol Struct Dyn; 2010 Dec; 28(3):309-21. PubMed ID: 20919747
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.
Istyastono EP; Nijmeijer S; Lim HD; van de Stolpe A; Roumen L; Kooistra AJ; Vischer HF; de Esch IJ; Leurs R; de Graaf C
J Med Chem; 2011 Dec; 54(23):8136-47. PubMed ID: 22003888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
